Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results

被引：0
|
作者：
Pujol, N. [1 ]
Pace-Loscos, T. [1 ]
Schiappa, R. [2 ]
Gautier, M. [1 ]
Chand, M. E. [1 ]
Levi, J. M. Hannoun [3 ]
机构：
[1] Antoine Lacassagne Canc Ctr, Nice, France
[2] Univ Cote Azur, Antoine Lacassagne Canc Ctr, Nice, France
[3] Univ Cote Azur, Ctr Antoine Lacassagne, Dept Radiotherapy, Nice, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2540
引用
收藏
页码：E242 / E242
页数：1
相关论文
共 50 条
  • [21] HDR brachytherapy in one fraction vs LDR brachytherapy in the treatment of localized prostate cancer. Early results.
    Agoston, P.
    Major, T.
    Jorgo, K.
    Frohlich, G.
    Gesztesi, L.
    Stelczer, G.
    Polgar, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S182 - S183
  • [22] HDR-Brachytherapy of localized prostate cancer -: Long term results in a single centre
    Stübinger, SH
    Van der Horst, C
    Erdt, O
    Overmoyer, K
    Braun, PM
    Juenemann, KP
    JOURNAL OF UROLOGY, 2006, 175 (04): : 216 - 216
  • [23] Two implant-fraction HDR-brachytherapy for prostate cancer: preliminary results and early toxicity
    Strouthos, I.
    Ferentinos, K.
    Karagiannis, E.
    Antorkas, G.
    Antoniou, A.
    Roussakis, Y.
    Zamba, N.
    Georgiou, E.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1977 - S1977
  • [24] Single Fraction Urethra-Sparing Prostate Cancer SBRT: Phase I Results of a Multicenter, Single Arm, Phase I/II Trial
    Zilli, T.
    Franzese, C.
    Giaj-Levra, N.
    Forster, R.
    Zwahlen, D. R.
    Koutsouvelis, N.
    Bertaut, A.
    Blanc, J.
    D'Agostino, G. R.
    Alongi, F.
    Guckenberger, M.
    Scorsetti, M.
    Miralbell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E316 - E317
  • [25] A Planning Study: Escalating the Single Fraction Monotherapy Dose for HDR Prostate Brachytherapy
    Sabondjian, Eric
    Sankreacha, Raxa
    Yuen, Jasper
    Rauth, Sarah
    MEDICAL PHYSICS, 2019, 46 (11) : 5378 - 5378
  • [26] Single fraction HDR brachytherapy in low-risk prostate cancer: a search for the best dose level
    Luthart, L.
    Kolkman-Deurloo, I. K. K.
    Busser, W. M. H.
    Aluwini, S.
    Christianen, M. E. M. C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1251 - S1251
  • [27] HDR brachytherapy in monotherapy of one fraction in patients with prostate cancer at low risk
    Orduz Arenas, A. C.
    Jimenez Garcia, I.
    Martinez Gutierrez, R.
    Cucarella Beltran, P.
    Blanco Parajon, S.
    Gonzalez Suarez, H. A.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S947 - S947
  • [28] PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
    Reynaud, Thomas
    Hathout, Lara
    Carignan, Damien
    Barkati, Maroie
    Martin, Andre-Guy
    Foster, William
    Lacroix, Frederic
    Delouya, Guila
    Taussky, Daniel
    Morton, Gerard
    Vigneault, Eric
    BRACHYTHERAPY, 2021, 20 (06) : 1090 - 1098
  • [29] Salvage HDR brachytherapy for prostate cancer recurrence: comparison of two fraction schedules
    Stankiewicz, M.
    Kellas-Sleczka, S.
    Szlag, M.
    Wojcieszek, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S518 - S520
  • [30] 21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study
    Salari, Kamran
    Hazy, Allison J.
    Ye, Hong
    Sebastian, Evelyn
    Limbacher, Amy
    Johnson, Matthew
    Mitchell, Beth
    Thompson, Andrew B.
    Seymour, Zachary A.
    Nandalur, Sirisha R.
    Krauss, Daniel J.
    BRACHYTHERAPY, 2024, 23 (03) : 321 - 328
12345